Information  X 
Enter a valid email address
  Print          More announcements

Friday 13 May, 2022

Competition and Mkts

Merger Update: VetPartners / Goddard

RNS Number : 3062L
Competition and Markets Authority
13 May 2022

Completed acquisition by Scooby Bidco Limited, trading through its subsidiary VetPartners Limited of Goddard Holdco Limited


CMA to look at VetPartners undertakings offer in detail

On 28 April 2022, the CMA announced that it is or may be the case that the above Merger has resulted or may be expected to result in a substantial lessening of competition within a market or markets in the United Kingdom.

On 6 May 2022, VetPartners Limited offered undertakings to the CMA. The CMA has considered the undertakings offered and today announced that it considers that there are reasonable grounds for believing that the undertaking offered, or a modified version of it, might be accepted by the CMA to remedy the substantial lessening of competition identified by the CMA.

The CMA now has until 12 July 2022 to decide whether to accept the undertakings, with the possibility to extend this timeframe to 7 September 2022 if it considers there are special reasons for doing so.

The text of this decision will be placed on the Competition and Markets Authority's website at   as soon as is reasonably practical.

In the event of media enquiries please email  [email protected]   .


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

a d v e r t i s e m e n t